In this feature story, Professor Kuhn shares his personal journey of how his mother’s diagnosis drove him to leave physics and tackle the challenges facing cancer biomedicine. He now leads the Convergent Science Initiative in Cancer (CSI-Cancer) at the USC Michelson Center for Convergent Bioscience where cutting-edge tools are being developed to improve outcomes for... Read More
New research projects at the Kuhn-Hicks laboratory aim to develop computational technologies to map cancer evolution and predict treatment response. Through collaboration with the FDA on breast cancer) and funding by the Adelson Medical Research Foundation for multiple myeloma, the goal of these projects is to deploy novel machine learning and spatiotemporal models that would assist clinicians... Read More
A recent article in The Guardian highlights research from our lab on how fitness technologies are being used to monitor and predict how patients respond to chemotherapy. Led by Keck School of Medicine’s Dr Jorge Nieva, our clinical collaborator, the work emphasizes the efforts to use fitness trackers as objective measures for patient’s quality of... Read More
The Kuhn-Hicks laboratory are using metal-tagged antibodies to map the proteins expressed on cancer cells circulating in the blood and in the bone marrow from a prostate cancer patient. The study, published in January by Convergent Science Physical Oncology, describes the approach of using an imaging mass cytometer to quantitate and localize 35 different protein markers... Read More
A new publication from Dr. James Hicks describing the utility of single-cell genomics from prostate biopsies towards improving diagnosis and prognosis in prostate cancer. See the Cancer Research article here.
The Kuhn and Hicks Laboratory at the USC Michelson Center for Convergent Bioscience (Los Angeles, CA) is looking for three postdoctoral fellows to focus on specific single cell and liquid biopsy projects in breast, lung and prostate cancer. Critical to being a successful candidate are the determination to improving outcomes for cancer patients through scientific... Read More
USC’s Convergent Science Initiative in Cancer and the USC Jimmy Iovine and Andre Young Academy have developed a new interdisciplinary undergraduate track to launch in the fall of 2019. Students in this new educational track will interact with physicians, scientists, patients and graduate students to develop innovative health solutions. Click here to read more.
Dr. Peter Kuhn and Dr. Valery Folkin of the USC Michelson Center for Convergent Bioscience discuss the role of the new Michelson Center building and a supportive culture in encouraging interdisciplinary collaboration. Click here to read more.
Dr. James Hicks, professor of biologic sciences at the USC Michelson Center for Convergent Bioscience and professor at the Keck School of Medicine at USC, and Liya Xu, a postdoctoral fellow published work showing that the chromosomal changes in the DNA found in the eye’s aqueous humor parallel chromosomal changes found in the retinoblastoma tumor.... Read More
Dr. Peter Kuhn, Dean’s Professor of Biological Sciences and a founding member of the USC Michelson Center for Convergent Bioscience, traveled to Vietnam to discuss a multidisciplinary approach to understanding cancer evolution and forecasting an individual patient’s progress. One goal is to put the cancer patient at the center. Click here to read more.